Are stimulants overprescribed for youths with ADHD?

Research output: Contribution to journalArticle

Abstract

Critics of stimulant treatment for youths with attention deficit hyperactivity disorder (ADHD) have increased their rhetoric of late, contending that the leading medication for it, Ritalin®, is vastly overprescribed. Additionally, they claim that Ritalin (methylphenidate) is inherently dangerous and that the entire system of the diagnosis and treatment of ADHD is seriously flawed. The critics view the underlying reason for the 'epidemic' as societal, due to our modern pace of living, our competitive society, and our consumer emphasis. Rejoinders to and clarifications of the more tangible points of the critics are presented, followed by a discussion of some more practical and legitimate concerns for researchers in this area. These concerns include changes within the ADHD category, the clinical need for multiple sources of diagnostic data, infrequent teacher-physician communication, problematic ADHD/conduct disorder comorbidity in adolescence, and the limited amount of community-based research.

Original languageEnglish (US)
Pages (from-to)55-62
Number of pages8
JournalAnnals of Clinical Psychiatry
Volume12
Issue number1
DOIs
StatePublished - 2000

Fingerprint

Attention Deficit Disorder with Hyperactivity
Methylphenidate
Conduct Disorder
Information Storage and Retrieval
Comorbidity
Communication
Research Personnel
Physicians
Therapeutics
Research

Keywords

  • Attention-deficit hyperactivity disorder
  • Controversy
  • Methylphenidate
  • Stimulants

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Are stimulants overprescribed for youths with ADHD? / Safer, Daniel J.

In: Annals of Clinical Psychiatry, Vol. 12, No. 1, 2000, p. 55-62.

Research output: Contribution to journalArticle

@article{e42f3e9cf5264f70a199ef7ba177b28b,
title = "Are stimulants overprescribed for youths with ADHD?",
abstract = "Critics of stimulant treatment for youths with attention deficit hyperactivity disorder (ADHD) have increased their rhetoric of late, contending that the leading medication for it, Ritalin{\circledR}, is vastly overprescribed. Additionally, they claim that Ritalin (methylphenidate) is inherently dangerous and that the entire system of the diagnosis and treatment of ADHD is seriously flawed. The critics view the underlying reason for the 'epidemic' as societal, due to our modern pace of living, our competitive society, and our consumer emphasis. Rejoinders to and clarifications of the more tangible points of the critics are presented, followed by a discussion of some more practical and legitimate concerns for researchers in this area. These concerns include changes within the ADHD category, the clinical need for multiple sources of diagnostic data, infrequent teacher-physician communication, problematic ADHD/conduct disorder comorbidity in adolescence, and the limited amount of community-based research.",
keywords = "Attention-deficit hyperactivity disorder, Controversy, Methylphenidate, Stimulants",
author = "Safer, {Daniel J.}",
year = "2000",
doi = "10.1023/A:1009031211900",
language = "English (US)",
volume = "12",
pages = "55--62",
journal = "Annals of Clinical Psychiatry",
issn = "1040-1237",
publisher = "Dowden Health Media,Inc",
number = "1",

}

TY - JOUR

T1 - Are stimulants overprescribed for youths with ADHD?

AU - Safer, Daniel J.

PY - 2000

Y1 - 2000

N2 - Critics of stimulant treatment for youths with attention deficit hyperactivity disorder (ADHD) have increased their rhetoric of late, contending that the leading medication for it, Ritalin®, is vastly overprescribed. Additionally, they claim that Ritalin (methylphenidate) is inherently dangerous and that the entire system of the diagnosis and treatment of ADHD is seriously flawed. The critics view the underlying reason for the 'epidemic' as societal, due to our modern pace of living, our competitive society, and our consumer emphasis. Rejoinders to and clarifications of the more tangible points of the critics are presented, followed by a discussion of some more practical and legitimate concerns for researchers in this area. These concerns include changes within the ADHD category, the clinical need for multiple sources of diagnostic data, infrequent teacher-physician communication, problematic ADHD/conduct disorder comorbidity in adolescence, and the limited amount of community-based research.

AB - Critics of stimulant treatment for youths with attention deficit hyperactivity disorder (ADHD) have increased their rhetoric of late, contending that the leading medication for it, Ritalin®, is vastly overprescribed. Additionally, they claim that Ritalin (methylphenidate) is inherently dangerous and that the entire system of the diagnosis and treatment of ADHD is seriously flawed. The critics view the underlying reason for the 'epidemic' as societal, due to our modern pace of living, our competitive society, and our consumer emphasis. Rejoinders to and clarifications of the more tangible points of the critics are presented, followed by a discussion of some more practical and legitimate concerns for researchers in this area. These concerns include changes within the ADHD category, the clinical need for multiple sources of diagnostic data, infrequent teacher-physician communication, problematic ADHD/conduct disorder comorbidity in adolescence, and the limited amount of community-based research.

KW - Attention-deficit hyperactivity disorder

KW - Controversy

KW - Methylphenidate

KW - Stimulants

UR - http://www.scopus.com/inward/record.url?scp=0034101974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034101974&partnerID=8YFLogxK

U2 - 10.1023/A:1009031211900

DO - 10.1023/A:1009031211900

M3 - Article

C2 - 10798827

AN - SCOPUS:0034101974

VL - 12

SP - 55

EP - 62

JO - Annals of Clinical Psychiatry

JF - Annals of Clinical Psychiatry

SN - 1040-1237

IS - 1

ER -